Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lopez

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
Genes|May 25, 2024
Characterization of the Common Genetic Variation in the Spanish Population of NavarreAlberto Maillo, Estefania Huergo, María Apellániz-Ruiz, et al.
Journal for Immunotherapy of Cancer|March 8, 2023
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppressionSofia Bruni, Florencia L Mauro, Cecilia J Proietti, et al.
Oncogene|August 27, 2020
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growthMaría F Chervo, Rosalía I Cordo Russo, Ezequiel Petrillo, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinomaDavid Piquemal, Roman Bruno, Barbara Bournet, et al.
BMC Health Services Research|December 30, 2025
The impact of COVID-19 social disruptions on general-, mental- and substance use healthcare services among people with and without HIV in the United StatesJenni M Wise, Jun Y Byun, Lorie Benning, et al.
Hormones & Cancer|July 8, 2020
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good PrognosisSantiago Madera, María F Chervo, Violeta A Chiauzzi, et al.
The Lancet. Oncology|March 28, 2024
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 studyStefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, et al.
PNAS Nexus|August 25, 2022
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I moleculesKyle R Jackson, Dinler A Antunes, Amjad H Talukder, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 22, 2025
Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections)Florent Eymard, Karine Louati, Éric Noel, et al.
Molecular Cancer Therapeutics|September 23, 2021
Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III TrialJavier Martin-Broto, Maria Lopez-Alvarez, David S Moura, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Genes|May 25, 2024
Characterization of the Common Genetic Variation in the Spanish Population of NavarreAlberto Maillo, Estefania Huergo, María Apellániz-Ruiz, et al.
Journal for Immunotherapy of Cancer|March 8, 2023
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppressionSofia Bruni, Florencia L Mauro, Cecilia J Proietti, et al.
Oncogene|August 27, 2020
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growthMaría F Chervo, Rosalía I Cordo Russo, Ezequiel Petrillo, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinomaDavid Piquemal, Roman Bruno, Barbara Bournet, et al.
BMC Health Services Research|December 30, 2025
The impact of COVID-19 social disruptions on general-, mental- and substance use healthcare services among people with and without HIV in the United StatesJenni M Wise, Jun Y Byun, Lorie Benning, et al.
Hormones & Cancer|July 8, 2020
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good PrognosisSantiago Madera, María F Chervo, Violeta A Chiauzzi, et al.
The Lancet. Oncology|March 28, 2024
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 studyStefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, et al.
PNAS Nexus|August 25, 2022
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I moleculesKyle R Jackson, Dinler A Antunes, Amjad H Talukder, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 22, 2025
Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections)Florent Eymard, Karine Louati, Éric Noel, et al.
Molecular Cancer Therapeutics|September 23, 2021
Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III TrialJavier Martin-Broto, Maria Lopez-Alvarez, David S Moura, et al.
Pageof 25